0001209191-15-049211.txt : 20150602
0001209191-15-049211.hdr.sgml : 20150602
20150602200804
ACCESSION NUMBER: 0001209191-15-049211
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150529
FILED AS OF DATE: 20150602
DATE AS OF CHANGE: 20150602
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABIOMED INC
CENTRAL INDEX KEY: 0000815094
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 042743260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 22 CHERRY HILL DR
CITY: DANVERS
STATE: MA
ZIP: 01923
BUSINESS PHONE: 9787775410
MAIL ADDRESS:
STREET 1: 22 CHERRY HILL DRIVE
CITY: DANVERS
STATE: MA
ZIP: 01923
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SUTTER MARTIN P
CENTRAL INDEX KEY: 0001017832
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-09585
FILM NUMBER: 15908499
MAIL ADDRESS:
STREET 1: 2170 BUCKTHORNE PLACE
STREET 2: SUITE 170
CITY: THE WOODLAND
STATE: TX
ZIP: 77380
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-29
0
0000815094
ABIOMED INC
ABMD
0001017832
SUTTER MARTIN P
21 WATERWAY AVENUE, SUITE 225
THE WOODLANDS
TX
77380
1
0
0
0
Common Stock, $0.01 par value
2015-05-19
4
J
0
24747
67.74
A
150369
D
Common Stock, $0.01 par value
2015-05-29
4
P
0
7500
60.17
A
157869
D
Common Stock, $0.01 par value
946818
I
By Essex Woodlands Health Ventures Fund VI, L.P.
Common Stock, $0.01 par value
1203182
I
By Essex Woodlands Health Ventures Fund VII, L.P.
Stock option (right to buy)
13.91
2009-05-20
2018-05-20
Common Stock
25000
25000
D
Stock option (right to buy)
18.63
2009-08-12
2018-08-13
Common Stock
12000
12000
D
Stock option (right to buy)
7.67
2010-08-11
2019-08-12
Common Stock
12000
12000
D
Stock option (right to buy)
9.99
2011-08-10
2020-08-11
Common Stock
12000
12000
D
Mr. Sutter received 24,747 shares of Common Stock as a payment-in-kind distribution from Essex Woodlands Health Ventures Fund VII, L.P. ("Fund VII") to its general partner and limited partners of an aggregate payment-in-kind distribution of 1,000,000 shares of Common Stock.
On May 29, 2015, Mr. Sutter purchased an aggregate of 7,500 shares of Common Stock of the Issuer in multiple open market transactions, with prices ranging from $59.80 to $60.50.
These securities are held by Essex Woodlands Health Ventures Fund VI, L.P. ("Fund VI"). Mr. Sutter is a managing director of Essex Woodlands Health Ventures VI, L.P., the general partner that manages Fund VI. As managing director, Mr. Sutter shares voting and investment powers for Fund VI. Mr. Sutter disclaims beneficial ownership of all such securities except to the extent of his pecuniary interest therein.
On May 19, 2015, Fund VII made a payment-in-kind distribution of 1,000,000 shares of Issuer's Common Stock to its partners pro-rata based on their respective interests in Fund VII rather than selling the shares and distributing the proceeds.
These securities are held by Fund VII. Mr. Sutter is a managing director of Essex Woodlands Health Ventures VII, L.P., the general partner that manages Fund VII. As managing director, Mr. Sutter shares voting and investment powers for Fund VII. Mr. Sutter disclaims beneficial ownership of all such securities except to the extent of his pecuniary interest therein.
Grant to reporting person to buy shares of Common Stock of Issuer under ABIOMED, Inc. 2000 Stock Incentive Plan.
These options become exercisable in annual 20% increments commencing on the date set forth in Table II, Column 6.
Grant to reporting person of option to buy shares of Common Stock of Issuer set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
/s/ Martin P. Sutter
2015-06-02